Gene therapy treatments for rare diseases are being developed, but getting them out of the lab has proved challenging.
This past spring, a biotech company announced the first use of a new gene-editing technology in people to fix an errant gene that causes a severe immune disorder. In June, a baby born with a life-threatening metabolic disorder was allowed to leave th... [272 chars]